Nppa

NPPA directs firms to issue revised price lists instead of recalling stock; compliance to be ensured at retailer level

NPPA slashes prices of 37 essential drugs, including paracetamol, atorvastatin, amoxycillin

Price ceilings, issued by the National Pharmaceutical Pricing Authority (NPPA), cover medicines used to treat various conditions ranging from infections, heart ailments, and inflammation to diabetes and vitamin deficiencies.

Essential medicines to be slightly costlier from April 1

There are around 800 drugs on the National List of Essential Medicines maintained by the Department of Pharmaceuticals. The pricing is arrived at by the National Pharmaceutical Pricing Authority on the basis of the WPI of the previous calendar year.

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Moneycontrol Selects National Edition: Top stories this morning

Our specially curated national news edition to help you stay at the top of your game.

Drug pricing watchdog fixes retail rates for 19 formulations, including cancer pills

Cancer medication Trastuzumab manufactured by Hetero Biopharma Limited and Mankind Pharma Limited will have a ceiling price of Rs 15817.49 per vial.

National drug pricing body fixes ceiling prices of 51 drugs and 2 formulations

The price of 24 anti-diabetic formulations that lead with dapagliflozin and another 14 with vildagliptin and two with sitagliptin molecules were set

Will rise in price caps of essential drugs expose chinks in price control policy?

Advocates of patients’ rights say the increases undermine the purpose of setting prices of essential medicines and wholesale inflation may not be the most appropriate basis.

Commonly used medicines to get 12% more expensive from April

Prices of non-scheduled drugs, on the other hand, are set to go up by up to 10 percent as per government rules.

Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why

They allege that the practice of selling medicines online is wrong, as these online pharmacies threaten the very existence of retailers. Also, they say, the online pharmacies are selling medicines at less than production price.

Centre defends pharma marketing practice code in SC, claims adequacy

Responding to a sales rep body’s demand for statutory backing to the Pharmaceutical Marketing Practices code UCMCP, the Centre said it was taking progressive steps to evaluate the necessity of making the code statutory, adding that it was a ‘time-consuming process, which cannot be completed in haste’.

Mansukh Mandaviya asks pharma industry to tackle spurious drug menace

Out of 84,874 samples tested by various drug controllers, up to 2,652 samples were not of standard quality last year, the Centre informed Parliament in July.

In Depth | Spadework begins for affordable medicines in India

As concerns grow about the rising unaffordability of drugs in India despite the country’s growing prowess as a pharma manufacturer, the government is looking to rework the way prices of medicines are determined

Retail prices of common medicines set to rise by a steep 11%

Industry insiders say that this will be the steepest ever rise in medicines included in the National List of Essential Medicines.

Kamlesh Kumar Pant appointed new NPPA chairman

The pharmaceutical pricing agency was currently headed by IAS officer Shubhra Singh, who was appointed to the post in 2018.

50% costlier now: NPPA approves price rise for Carbamazepine, Ranitidine, Ibuprofen

The drug price regulation authority said that the "one-time price increase" of 50 percent is an "exceptional measure."

NPPA asks drug firms to cut prices in wake of GST rate reduction

The NPPA is mandated to fix and revise the prices of controlled bulk drugs and formulations, and to enforce prices and availability of the medicines in the country.

COVID-19 update | Health Ministry allocates Remdesivir supply to 19 states, UTs; production to be ramped up

The production capacity of domestic Remdesivir manufacturers has been ramped up keeping in mind the sudden surge in demand in the country.

Prices of N-95 masks down by up to 47% after NPPA advisory

N-95 masks were earlier being sold in the market for Rs 150 to 300 per unit and after the advisory by the the National Pharmaceutical Pricing Authority (NPPA), prices have been cut.

Exclusive | COVID-19: NPPA seeks urgent supply details on gloves, PPEs, kits, and ventilators as hoarding fears rise

The drug regulator has also sought details of stock in hand of these items at the retail level –pharmacies, drug and chemist stores, amid fears of hoarding by retailers, producers and even wealthy individuals.

COVID-19: NPPA asks manufacturers to provide details about stock availability of key HIV, malaria drugs

The government on Wednesday had banned export of anti-malarial drug hydroxycloroquine, with immediate effect to ensure sufficient availability of the medicine in the domestic market.

Coronavirus pandemic | NPPA asks state regulators to ensure masks, sanitisers not sold above MRP

NPPA Chairman Shubhra Singh on March 12 met representatives of pharmaceutical industry associations on the issue of availability of critical active pharmaceutical ingredients (APIs).

Government may list 'essential medical devices', cap trade margin in 30-50% range

The Indian Council of Medical Research may finalise the list after meeting stakeholders on July 26.